Mitochondria in health, disease, and aging

JS Harrington, SW Ryter, M Plataki… - Physiological …, 2023 - journals.physiology.org
Mitochondria are well known as organelles responsible for the maintenance of cellular
bioenergetics through the production of ATP. Although oxidative phosphorylation may be …

Molecular mechanisms and consequences of mitochondrial permeability transition

M Bonora, C Giorgi, P Pinton - Nature reviews Molecular cell biology, 2022 - nature.com
Mitochondrial permeability transition (mPT) is a phenomenon that abruptly causes the flux of
low molecular weight solutes (molecular weight up to 1,500) across the generally …

NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

N **e, L Zhang, W Gao, C Huang, PE Huber… - Signal transduction and …, 2020 - nature.com
Nicotinamide adenine dinucleotide (NAD+) and its metabolites function as critical regulators
to maintain physiologic processes, enabling the plastic cells to adapt to environmental …

Mitochondrial dysfunction in pathophysiology of heart failure

B Zhou, R Tian - The Journal of clinical investigation, 2018 - Am Soc Clin Investig
Mitochondrial dysfunction has been implicated in the development of heart failure. Oxidative
metabolism in mitochondria is the main energy source of the heart, and the inability to …

Therapeutic potential of NAD-boosting molecules: the in vivo evidence

L Rajman, K Chwalek, DA Sinclair - Cell metabolism, 2018 - cell.com
Nicotinamide adenine dinucleotide (NAD), the cell's hydrogen carrier for redox enzymes, is
well known for its role in redox reactions. More recently, it has emerged as a signaling …

The mitochondrial permeability transition: Recent progress and open questions

P Bernardi, M Carraro, G Lippe - The FEBS journal, 2022 - Wiley Online Library
Major progress has been made in defining the basis of the mitochondrial permeability
transition, a Ca2+‐dependent permeability increase of the inner membrane that has puzzled …

Therapeutic targets for cardiac fibrosis: from old school to next-gen

JG Travers, CA Tharp, M Rubino… - The Journal of clinical …, 2022 - Am Soc Clin Investig
Cardiovascular diseases remain the leading cause of death worldwide, with pathological
fibrotic remodeling mediated by activated cardiac myofibroblasts representing a unifying …

Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases

AE Kane, DA Sinclair - Circulation research, 2018 - Am Heart Assoc
The sirtuin family of nicotinamide adenine dinucleotide–dependent deacylases (SIRT1–7)
are thought to be responsible, in large part, for the cardiometabolic benefits of lean diets and …

NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction

D Tong, GG Schiattarella, N Jiang… - Circulation …, 2021 - Am Heart Assoc
Rationale: Heart failure with preserved ejection fraction (HFpEF) is a mortal clinical
syndrome without effective therapies. We recently demonstrated in mice that a combination …

Signaling pathways related to oxidative stress in diabetic cardiomyopathy

M Peng, Y Fu, C Wu, Y Zhang, H Ren… - Frontiers in …, 2022 - frontiersin.org
Diabetes is a chronic metabolic disease that is increasing in prevalence and causes many
complications. Diabetic cardiomyopathy (DCM) is a complication of diabetes that is …